Maui: My price target for November was in the .30
Post# of 30025
1) LymPro Revenue Guidance,
2) Lympro Partnership Announcement, &
3) LymPro "Bridge Data"
Based on my "interpretation" of how I feel those 3 catalysts are doing, I have lowered my price target down to the .15 to .20 to .25 cent range for November, more in line with the .20 cent Price Target of Jason Napodano. By criticizing me, you are criticizing his analysis of the company, too!
My reason for raising my concerns is because I think they are valid, and because of the shareholder meeting coming up with the vote on the billion shares. I think my concerns ought to be discussed and debated. I no longer believe Gerald should dangle carrots in front of us about catalysts that he can't legally talk about in the same blog he talks about raising the authorized shares by a billion!! I want concrete catalysts that raise our pps from .107 cents....before the vote!!
I am not a flipper.
I hope I am stupid....but I know better.